NSE - Delayed Quote INR

Hester Biosciences Limited (HESTERBIO.NS)

1,655.00
-33.20
(-1.97%)
At close: May 9 at 3:29:31 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
3,084,320
3,045,460
2,660,910
2,350,060
2,143,320
Cost of Revenue
1,034,270
1,101,820
858,190
725,380
589,780
Gross Profit
2,050,050
1,943,640
1,802,720
1,624,680
1,553,540
Operating Expense
1,577,810
1,520,840
1,387,070
1,059,950
965,940
Operating Income
472,240
422,800
415,650
564,730
587,600
Net Non Operating Interest Income Expense
-17,690
-75,220
-33,070
-16,300
-53,100
Pretax Income
456,930
319,530
401,540
535,020
501,030
Tax Provision
120,130
107,870
121,190
140,180
154,050
Net Income Common Stockholders
311,470
188,890
266,270
393,200
344,300
Diluted NI Available to Com Stockholders
311,470
188,890
266,270
393,200
344,300
Basic EPS
36.91
22.20
31.30
46.22
40.47
Diluted EPS
36.91
22.20
31.30
46.22
40.47
Basic Average Shares
8,611.35
8,506.87
8,506.87
8,506.87
8,506.87
Diluted Average Shares
8,611.35
8,506.87
8,506.87
8,506.87
8,506.87
Rent Expense Supplemental
--
23,310
15,450
13,070
13,140
Total Expenses
2,612,080
2,622,660
2,245,260
1,785,330
1,555,720
Net Income from Continuing & Discontinued Operation
311,470
188,890
266,270
393,200
344,300
Normalized Income
306,361.94
184,299.57
268,553.11
407,008.62
371,972.30
Interest Income
--
19,070
21,730
19,030
12,940
Interest Expense
33,660
91,190
51,490
25,760
60,620
Net Interest Income
-17,690
-75,220
-33,070
-16,300
-53,100
EBIT
490,590
410,720
453,030
560,780
561,650
EBITDA
654,270
582,460
659,980
726,590
694,790
Reconciled Cost of Revenue
1,034,270
1,101,820
858,190
725,380
589,780
Reconciled Depreciation
163,680
171,740
206,950
165,810
133,140
Net Income from Continuing Operation Net Minority Interest
311,470
188,890
266,270
393,200
344,300
Total Unusual Items Excluding Goodwill
6,930
6,930
-3,270
-18,610
-39,960
Total Unusual Items
6,930
6,930
-3,270
-18,610
-39,960
Normalized EBITDA
647,340
575,530
663,250
745,200
734,750
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,821.94
2,339.57
-986.89
-4,801.38
-12,287.70
3/31/2021 - 3/13/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INNOVACAP.NS Innova Captab Limited
849.50
-4.30%
 
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,524.00
-1.30%
 
ZYDUSLIFE.BO Zydus Lifesciences Limited
879.60
+0.89%
 
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,140.00
-1.44%
 
MANKIND.NS Mankind Pharma Limited
2,404.00
-1.46%
 
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,393.00
-1.83%
 
ZYDUSLIFE.NS Zydus Lifesciences Limited
880.90
+0.82%
 
LUPIN.NS Lupin Limited
2,035.00
+1.00%
 
NATCOPHARM.NS NATCO Pharma Limited
810.20
+0.96%
 
CIPLA.NS Cipla Limited
1,477.00
-0.66%